MENU
ALPMY
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION

Astellas Pharma (ALPMY) Ownership - Who owns Astellas Pharma?

Astellas Pharma Inc is a specialty international pharmaceutical company... Show more

Profile

Industry
N/A
Address
2-5-1, Nihonbashi-Honcho
Phone
+81 332443000
Employees
16243
Web
http://www.astellas.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
23.62B
P/E Ratio
29.32
Total Cash
295.74B
Projected Growth
N/A
Total Debt
740.54B
Revenue
2.01T
Risk (Beta)
-0.04
Dividend Yield
0.04
Total Cash/Share
165.11
Total Debt/Equity
N/A
Revenue/Share
7.17 USD as % of share price

Fundamentals

ALPMY
Capitalization
23.6B
P/E Ratio
29.32
Risk (Beta)
-0.04
Dividend Yield
0.04
Total Cash
296B
Total Cash/Share
165.11
Total Debt
741B
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
7.17%
Revenue
2.01T
ROE
N/A
Book Value
1.61T
P/B Ratio
2.26
Cash Flow
N/A
Earnings
69.73
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
103B
Current Ratio
1.03
Current Revenue Per Employee
28100990.00
Dividends Per Share - Security
N/A
EBITDA
347B
Float
N/A
Float - Current
N/A
Gross Income Margin
82.34
Revenue To Assets
3.61
Shares Held By Institutions
10.1M
Shares Outstanding - Current
1.79B
Total Liabilities
1.84T
Total Volume MTD
N/A
Value
1
Gain YTD
36.718
View a ticker or compare two or three
ALPMY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ALPMY showed earnings on October 30, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
N/A
Address
2-5-1, Nihonbashi-Honcho
Phone
+81 332443000
Employees
16243
Web
http://www.astellas.com